BioAesthetics’ mission is to transform lives through advancement in biomaterials.
BioAesthetics was founded by Dr. Nicholas Pashos in 2015 as a spin-out from Tulane University in New Orleans, Louisiana. In 2017 BioAesthetics was accepted into IndieBio, the world’s largest biotech accelerator, located in San Francisco, California.
While at IndieBio BioAesthetics closed its Series Seed in Q4, 2017. In Q2, 2018, BioAesthetics headquarters was relocated to Research Triangle Park, North Carolina, to take advantage of the area’s talent and deep biotech roots.
The company is currently commercializing its inaugural product: a tissue-engineered nipple-areolar complex graft (NACgraft). BioAesthetics is focusing its product pipeline on acellular regenerative grafts for advanced wound and reconstructive care.